Advanced Oncotherapy (LON:AVO) Shares Pass Below Two Hundred Day Moving Average of $28.28

Advanced Oncotherapy plc (LON:AVOGet Rating) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 28.28 ($0.34) and traded as low as GBX 22.75 ($0.28). Advanced Oncotherapy shares last traded at GBX 22.75 ($0.28), with a volume of 55,061 shares traded.

The stock has a market cap of £106.96 million and a price-to-earnings ratio of -2.59. The company has a current ratio of 0.91, a quick ratio of 0.08 and a debt-to-equity ratio of 161.92. The stock’s 50-day moving average price is GBX 22.99 and its 200-day moving average price is GBX 28.28.

Advanced Oncotherapy Company Profile (LON:AVO)

Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, selling, and maintaining proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties.

Featured Articles

Want More Great Investing Ideas?

Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.